Search Results for keywords:"Centers for Disease Control and Prevention"

The National Institute of Allergy and Infectious Diseases (NIAID) announced a closed meeting to discuss and evaluate contract proposals as part of a collaborative effort with the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). This meeting is set to take place virtually on February 2, 2021, from 11:00 a.m. to 4:00 p.m. The discussions will include confidential trade secrets or commercial information and personal details, so it will be closed to the public. Dr. Lynn Rust is the contact person for more information about this meeting.

The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. The meeting will take place on May 6, 2021, via teleconference. It will focus on reviewing grant applications related to increasing genetic counseling referrals for those at risk for BRCA-associated cancers. The content discussed in the meeting includes confidential material and personal information, thus it will be closed to the public.

The Centers for Disease Control and Prevention (CDC) has submitted a request for approval to continue collecting information for the World Trade Center (WTC) Health Program, which helps 9/11 responders and survivors. A revision to this request includes changes due to a new law expanding enrollment eligibility for additional responders and a new online portal for a Youth Research Cohort. The proposed changes will increase the information collection burden by 1,450 hours annually. The public can comment on these updates within 30 days.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. This meeting, scheduled for April 28, 2021, will be held via teleconference from 11:00 a.m. to 6:00 p.m. EDT. The purpose is to review and evaluate grant applications, which contain confidential information such as trade secrets and personal data. Due to the sensitive nature of the materials, the meeting will not be open to the public.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting notice in the Federal Register. The authority to sign such notices, which pertain to meetings and committee management activities for both the CDC and the Agency for Toxic Substances and Disease Registry, has been delegated to the Director of the Strategic Business Initiatives Unit. For further details, individuals can contact Mikel Walters, Ph.D., the Scientific Review Officer at the National Center for Injury Prevention and Control, by phone or email.

The Centers for Disease Control and Prevention (CDC) is seeking public comments on their study titled “Medication-Assisted Treatment (MAT) for Opioid Use Disorder,” which is under review by the Office of Management and Budget (OMB). This study aims to evaluate the effectiveness of different treatments for opioid use disorders, which affect about 2.4 million adults in the U.S. The CDC has extended the recruitment deadline due to lower than expected patient enrollment and requires OMB approval to continue data collection. The public can submit comments or suggestions concerning the necessity, methodology, and cost of the proposed information collection within 30 days of the notice's publication.